Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat

Experimental Neurology
B S BregmanP L Kuhn

Abstract

The capacity of CNS neurons for axonal regrowth after injury decreases as the age of the animal at time of injury increases. After spinal cord lesions at birth, there is extensive regenerative growth into and beyond a transplant of fetal spinal cord tissue placed at the injury site. After injury in the adult, however, although host corticospinal and brainstem-spinal axons project into the transplant, their distribution is restricted to within 200 micron of the host/transplant border. The aim of this study was to determine if the administration of neurotrophic factors could increase the capacity of mature CNS neurons for regrowth after injury. Spinal cord hemisection lesions were made at cervical or thoracic levels in adult rats. Transplants of E14 fetal spinal cord tissue were placed into the lesion site. The following neurotrophic factors were administered at the site of injury and transplantation: brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4), ciliary-derived neurotrophic factor (CNTF), or vehicle alone. After 1-2 months survival, neuroanatomical tracing and immunocytochemical methods were used to examine the growth of host axons within the transplants. The neurotrophin administration ...Continue Reading

References

Nov 1, 1992·Journal of Neurobiology·W D SniderQ Yan
Jan 1, 1991·Progress in Brain Research·L I Benowitz, N I Perrone-Bizzozero
Feb 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·B KnüselF Hefti
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T Savio, M E Schwab
Jun 1, 1989·Neuron·Y A Barde
Apr 15, 1989·The Journal of Comparative Neurology·B S BregmanA O'Neill
Apr 22, 1988·The Journal of Comparative Neurology·A TesslerP J Reier
May 15, 1986·The Journal of Comparative Neurology·P J ReierJ R Wujek
Feb 1, 1984·Journal of Neurocytology·P M RichardsonA J Aguayo
Mar 20, 1980·Nature·P M RichardsonA J Aguayo
May 1, 1994·Trends in Neurosciences·R M LindsayP S DiStefano
Jan 1, 1994·Stereotactic and Functional Neurosurgery·E Hitchcock
Nov 1, 1994·Journal of Neurobiology·Y A Barde
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Hagg, S Varon
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·S Mansour-RobaeyA J Aguayo
Mar 1, 1993·The European Journal of Neuroscience·R JenkinsS P Hunt
Sep 1, 1993·The European Journal of Neuroscience·L Schnell, M E Schwab

❮ Previous
Next ❯

Citations

Nov 18, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·S RochkindZ Nevo
Sep 10, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Edmund R Hollis, Mark H Tuszynski
Jul 22, 2006·Nature Reviews. Neuroscience·Noam Y Harel, Stephen M Strittmatter
Oct 1, 2003·Clinical and Experimental Pharmacology & Physiology·Lisa N Gillespie
Apr 10, 2002·Journal of Neurotrauma·Yu-Shang LeeRichard T Robertson
May 29, 2004·Tissue Engineering·Kazuya KataokaChizuka Ide
Feb 11, 2010·Journal of Neurotrauma·Rodrigo F Madeiro da CostaSergio T Ferreira
Mar 11, 2003·Annual Review of Neuroscience·Samuel David, Steve Lacroix
May 20, 1999·Annual Review of Pharmacology and Toxicology·M AschnerW J Streit
Jun 1, 2008·Biologics : Targets & Therapy·Masaki Ueno, Toshihide Yamashita
Jan 1, 2008·International Journal of Nanomedicine·Justin T Seil, Thomas J Webster
Feb 21, 2009·Neurosurgical Focus·Tessa Gordon
Apr 10, 2004·Neurological Research·Jason S BelkasRajiv Midha
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·W E LyonsL Tessarollo
Mar 25, 2004·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Sean Dennis ChristieIvar Mendez
Jun 30, 2006·Expert Opinion on Biological Therapy·Damien D Pearse, David J Barakat
Sep 20, 2015·Journal of Molecular Neuroscience : MN·Micaela Johanna GlatDaniel Offen
Jan 19, 2005·The European Journal of Neuroscience·Angela L M ScottMatt S Ramer
Nov 27, 2015·Experimental Neurology·Gabriel Martínez-GálvezCarlos B Mantilla
Jan 16, 2016·Cellular and Molecular Life Sciences : CMLS·John BiancoAnne des Rieux
Aug 12, 2009·Neuropeptides·Xue ZhouTing-Hua Wang
Aug 12, 2009·Respiratory Physiology & Neurobiology·Xiao-Ming Xu, Stephen M Onifer
Sep 12, 2009·Respiratory Physiology & Neurobiology·Carlos B Mantilla, Gary C Sieck

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.